Traxillaside is primarily used in pharmaceutical research due to its potential bioactive properties. It has shown promise as an anti-inflammatory agent in preclinical studies, making it a candidate for development in treatments targeting chronic inflammatory conditions. Additionally, it exhibits antioxidant activity, which may contribute to cellular protection against oxidative stress. Its natural origin and structural complexity also make it valuable in the study of metabolic pathways and enzyme inhibition, supporting drug discovery efforts in natural product chemistry. Research is ongoing to explore its efficacy and safety for therapeutic use.